Abstract
Introduction
The efficacy and safety of intravenous (IV) tranexamic acid (TXA) during hip fracture surgery remain controversial. This meta-analysis aimed to assess the efficacy of IV-TXA administration during hip fracture surgery for reducing the transfusion requirement and blood loss as well as its safety regarding the risk of thrombolysis.
Materials and methods
PubMed, EMBASE, Web of Science, and the Cochrane Library Database were systematically searched for randomized controlled trials (RCTs) that focused on the efficacy and safety of IV-TXA in patients during hip fracture surgery. The primary outcome was the transfusion requirement. Secondary outcomes included total blood loss (TBL), deep vein thrombosis (DVT), and total thromboembolic events (TTEs). Risk ratio (RR), risk difference (RD), and mean difference (MD) for dichotomous and continuous data outcomes were determined from the meta-analysis. Data were analyzed using Rev Man 5.3.
Results
Altogether, 11 RCTs were included (total sample size 892 patients). IV-TXA significantly reduced the transfusion requirement [RR 0.60, 95% confidence interval (CI) 0.38–0.93, P = 0.02] and TBL (MD 326.64 ml, 95% CI − 462.23 to − 191.06, P < 0.00001) vs. cosntrol group. IV-TXA caused no increased risk of DVT (RD 0.02, 95% CI − 0.01 to 0.04, P = 0.13) or TTEs (RD 0.02, 95% CI − 0.01 to 0.05, P = 0.12).
Conclusion
Available evidence indicates that IV-TXA efficaciously reduces TBL and transfusion requirements during hip fracture surgery without significantly increasing the risk of TTEs including DVT.
Similar content being viewed by others
References
Landefeld CS (2011) Goals of care for hip fracture: promoting independence and reducing mortality. Arch Intern Med 171(20):1837–1838
Chen W, Lv H, Liu S et al (2017) National incidence of traumatic fractures in China: a retrospective survey of 512 187 individuals. Lancet Glob Health 5(8):e807–e817
Carpintero P, Caeiro JR, Carpintero R et al (2014) Complications of hip fractures: a review. World J Orthop 5(4):402–411
Foss NB, Kristensen MT, Kehlet H (2008) Anaemia impedes functional mobility after hip fracture surgery. Age Ageing 37(2):173–178
Lawrence VA, Silverstein JH, Cornell JE et al (2003) Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion 43(12):1717–1722
Vamvakas EC, Blajchman MA (2009) Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113(15):3406–3417
Mahdy AM, Webster NR (2004) Perioperative systemic haemostatic agents. Br J Anaesth 93(6):842–858
Zhang S, Huang Q, Xu B et al (2018) Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: a large, single-center, retrospective study. Medicine 97(1):e9429
Duncan CM, Gillette BP, Jacob AK et al (2015) Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplast 30(2):272–276
Poeran J, Rasul R, Suzuki S et al (2014) Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. Bmj 349:g4829
Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–I16
Higgins JPT, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343(oct18 2):d5928
Huang Z, Ma J, Pei F et al (2013) Meta-analysis of temporary versus no clamping in TKA. Orthopedics 36(7):543–550
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 339:b2700
Schiavone A, Bisaccia M, Inkov I et al (2018) Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not? Folia Med (Plovdiv) 60(1):67–78
Gausden EB, Garner MR, Warner SJ et al (2016) Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients. BMJ Open 6(6):e010676
Moghaddam MJ, Darabi E, Sheikholeslamy F (2011) Effect of tranexamic acid in decreasing need to transfusion in hip fracture surgery. Eur J Anaesthesiol 28:89
Baruah RK, Borah PJ, Haque R (2016) Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. J Orthop Surg (Hong Kong) 24(3):379–382
Emara WM, Moez KK, Elkhouly AH (2014) Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res 8(1):48–53
Haghighi M, Ettehad H, Mardani-Kivi M et al (2017) Does tranexamic acid reduce bleeding during femoral fracture operation? Arch Bone Jt Surg 5(2):103–108
Lei J, Zhang B, Cong Y et al (2017) Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res 12(1):124
Mohib Y, Rashid RH, Ali M et al (2015) Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc 65(11 Suppl 3):S17–S20
Sadeghi M, Mehr-Aein A (2007) Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica 45(6):437–442
Tengberg PT, Foss NB, Palm H et al (2016) Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Bone Jt J 98-b (6):747–753
Tian S, Shen Z, Liu Y et al (2018) The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury 49(3):680–684
Vijay BS, Bedi V, Mitra S et al (2013) Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi J Anaesth 7(1):29–32
Watts CD, Houdek MT, Sems SA et al (2017) Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. J Orthop Trauma 31(7):345–351
Zufferey PJ, Miquet M, Quenet S et al (2010) Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 104(1):23–30
Spahn DR (2010) Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113(2):482–495
Lee C, Freeman R, Edmondson M et al (2015) The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study. Injury 46(10):1978–1982
Farrow LS, Smith TO, Ashcroft GP et al (2016) A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol 82(6):1458–1470
Zhang P, He J, Fang Y et al (2017) Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: a meta-analysis. Medicine (Baltimore) 96(21):e6940
Astedt B, Liedholm P, Wingerup L (1978) The effect of tranexamic acid on the fibrinolytic activity of vein walls. Annales Chirurgiae Et Gynaecologiae 67(6):203–205
Cionac Florescu S, Anastase DM, Munteanu AM et al (2013) Venous thromboembolism following major orthopedic surgery. Maedica (Buchar) 8(2):189–194
Edelsberg J, Ollendorf D, Oster G (2001) Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics. Am J Health Syst Pharm 58(Suppl 2):S4–S13
Maynard MJ, Sculco TP, Ghelman B (1991) Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop Relat Res 273(273):125–130
Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224–232
Xie J, Hu Q, Huang Q et al (2017) Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis. Thromb Res 153:28–36
Acknowledgements
We thank Jinwei Xie from West China Hospital, Sichuan University for providing language help and writing assistance.
Funding
This research received no specific Grant from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has financial or personal relationships with other people or organizations that could inappropriately influence this work.
Ethical approval
Because this study was a literature review, ethical approval was not obtained.
Informed consent
Not applicable.
Rights and permissions
About this article
Cite this article
Xiao, C., Zhang, S., Long, N. et al. Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg 139, 893–902 (2019). https://doi.org/10.1007/s00402-019-03118-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-019-03118-6